Metagenomi, Inc. (MGX)
NASDAQ: MGX · IEX Real-Time Price · USD
0.00 (0.00%)
May 17, 2024, 4:00 PM EDT - Market closed

Metagenomi Statistics

Total Valuation

Metagenomi has a market cap or net worth of $263.43 million. The enterprise value is -$21.16 million.

Market Cap 263.43M
Enterprise Value -21.16M

Important Dates

The last earnings date was Tuesday, May 14, 2024, after market close.

Earnings Date May 14, 2024
Ex-Dividend Date n/a

Share Statistics

Metagenomi has 37.47 million shares outstanding. The number of shares has increased by 521.79% in one year.

Shares Outstanding 37.47M
Shares Change (YoY) +521.79%
Shares Change (QoQ) +520.86%
Owned by Insiders (%) n/a
Owned by Institutions (%) n/a
Float n/a

Valuation Ratios

PE Ratio n/a
Forward PE n/a
PS Ratio 5.57
Forward PS n/a
PB Ratio 0.96
P/FCF Ratio n/a
PEG Ratio n/a
Financial Ratio History

Enterprise Valuation

EV / Earnings n/a
EV / Sales n/a
EV / EBIT n/a
EV / FCF n/a

Financial Position

The company has a current ratio of 4.75, with a Debt / Equity ratio of 0.17.

Current Ratio 4.75
Quick Ratio 4.73
Debt / Equity 0.17
Debt / EBITDA n/a
Debt / FCF n/a
Interest Coverage n/a

Financial Efficiency

Return on Equity (ROE) n/a
Return on Assets (ROA) n/a
Return on Capital (ROIC) n/a
Revenue Per Employee $200,246
Profits Per Employee -$327,415
Employee Count 236
Asset Turnover n/a
Inventory Turnover n/a


Income Tax n/a
Effective Tax Rate n/a

Stock Price Statistics

Beta (1Y) n/a
52-Week Price Change n/a
50-Day Moving Average 8.86
200-Day Moving Average n/a
Relative Strength Index (RSI) 43.85
Average Volume (30 Days) 133,414

Short Selling Information

Short Interest n/a
Short Previous Month n/a
Short % of Shares Out n/a
Short % of Float n/a
Short Ratio (days to cover) n/a

Income Statement

In the last 12 months, Metagenomi had revenue of $47.26 million and -$77.27 million in losses. Loss per share was -$2.06.

Revenue 47.26M
Gross Profit n/a
Operating Income n/a
Pretax Income n/a
Net Income -77.27M
EBIT n/a
Loss Per Share -$2.06
Full Income Statement

Balance Sheet

The company has $332.65 million in cash and $48.06 million in debt, giving a net cash position of $284.59 million or $7.59 per share.

Cash & Cash Equivalents 332.65M
Total Debt 48.06M
Net Cash 284.59M
Net Cash Per Share $7.59
Equity / Book Value 275.63M
Book Value Per Share 7.36
Working Capital 264.94M
Full Balance Sheet

Cash Flow

Operating Cash Flow n/a
Capital Expenditures n/a
Free Cash Flow n/a
FCF Per Share n/a
Full Cash Flow Statement


Gross Margin n/a
Operating Margin n/a
Pretax Margin n/a
Profit Margin -163.51%
EBITDA Margin n/a
EBIT Margin n/a
FCF Margin n/a

Dividends & Yields

Metagenomi does not appear to pay any dividends at this time.

Dividend Per Share n/a
Dividend Yield n/a
Dividend Growth (YoY) n/a
Years of Dividend Growth n/a
Payout Ratio n/a
Buyback Yield -521.79%
Shareholder Yield -521.79%
Earnings Yield -29.33%
FCF Yield n/a

Analyst Forecast

The average price target for Metagenomi is $17.83, which is 154.71% higher than the current price. The consensus rating is "Strong Buy".

Price Target $17.83
Price Target Difference 154.71%
Analyst Consensus Strong Buy
Analyst Count 7
Revenue Growth Forecast (5Y) n/a
EPS Growth Forecast (5Y) n/a
Stock Forecasts

Stock Splits

This stock does not have any record of stock splits.

Last Split Date n/a
Split Type n/a
Split Ratio n/a


Altman Z-Score n/a
Piotroski F-Score n/a